Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 4
2010 2
2011 6
2012 3
2013 4
2014 6
2015 8
2016 3
2017 7
2018 5
2019 6
2020 14
2021 20
2022 25
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
Maida E, Moccia M, Palladino R, Borriello G, Affinito G, Clerico M, Repice AM, Di Sapio A, Iodice R, Spiezia AL, Sparaco M, Miele G, Bile F, Scandurra C, Ferraro D, Stromillo ML, Docimo R, De Martino A, Mancinelli L, Abbadessa G, Smolik K, Lorusso L, Leone M, Leveraro E, Lauro F, Trojsi F, Streito LM, Gabriele F, Marinelli F, Ianniello A, De Santis F, Foschi M, De Stefano N, Morra VB, Bisecco A, Coghe G, Cocco E, Romoli M, Corea F, Leocani L, Frau J, Sacco S, Inglese M, Carotenuto A, Lanzillo R, Padovani A, Triassi M, Bonavita S, Lavorgna L; Digital Technologies, Web, Social Media Study Group of the Italian Society of Neurology (SIN). Maida E, et al. Among authors: iodice r. J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12328-x. Online ahead of print. J Neurol. 2024. PMID: 38568227
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Schiavetti I, Signori A, Albanese A, Frau J, Cocco E, Lorefice L, di Lemme S, Fantozzi R, Centonze D, Landi D, Marfia G, Signoriello E, Lus G, Zecca C, Gobbi C, Iodice R, Malimpensa L, Cordioli C, Ferraro D, Ruscica F, Pasquali L, Repice A, Immovilli P, Ferrò MT, Bonavita S, Di Filippo M, Abbadessa G, Govone F, Sormani MP; CladStop study group. Schiavetti I, et al. Among authors: iodice r. Eur J Neurol. 2024 Mar 28:e16250. doi: 10.1111/ene.16250. Online ahead of print. Eur J Neurol. 2024. PMID: 38549186
A Blood Test for the Diagnosis of Multiple Sclerosis.
Giuliano P, La Rosa G, Capozzi S, Cassano E, Damiano S, Habetswallner F, Iodice R, Marra M, Pavone LM, Quarantelli M, Vitelli G, Santillo M, Paternò R. Giuliano P, et al. Among authors: iodice r. Int J Mol Sci. 2024 Jan 30;25(3):1696. doi: 10.3390/ijms25031696. Int J Mol Sci. 2024. PMID: 38338973 Free PMC article.
Pregnancy experience in women with spinal muscular atrophy: a case series.
Bencivenga RP, Zoppi D, Russo A, Cassano E, Tozza S, Iodice R, Dubbioso R, Manganelli F, Ruggiero L. Bencivenga RP, et al. Among authors: iodice r. Acta Myol. 2023 Sep 30;42(2-3):60-64. doi: 10.36185/2532-1900-316. eCollection 2023. Acta Myol. 2023. PMID: 38090543 Free PMC article.
Multiple Sclerosis Progression and Relapse Activity in Children.
Iaffaldano P, Portaccio E, Lucisano G, Simone M, Manni A, Guerra T, Paolicelli D, Betti M, De Meo E, Pastò L, Razzolini L, Rocca MA, Ferrè L, Brescia Morra V, Patti F, Zaffaroni M, Gasperini C, De Luca G, Ferraro D, Granella F, Pozzilli C, Romano S, Gallo P, Bergamaschi R, Coniglio MG, Lus G, Vianello M, Banfi P, Lugaresi A, Totaro R, Spitaleri D, Cocco E, Di Palma F, Maimone D, Valentino P, Torri Clerici V, Protti A, Maniscalco GT, Salemi G, Pesci I, Aguglia U, Lepore V, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register. Iaffaldano P, et al. JAMA Neurol. 2024 Jan 1;81(1):50-58. doi: 10.1001/jamaneurol.2023.4455. JAMA Neurol. 2024. PMID: 38010712
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients.
Bisecco A, Matrone F, Capobianco M, De Luca G, Filippi M, Granella F, Lus G, Marfia GA, Mirabella M, Patti F, Trojano M, Mascolo A, Copetti M, Tedeschi G, Gallo A; OCREVID study group on behalf of the Italian MS Register. Bisecco A, et al. J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20. J Neurol. 2024. PMID: 37982852 Free PMC article.
Intra- and Extra-Hospitalization Monitoring of Vital Signs-Two Sides of the Same Coin: Perspectives from LIMS and Greenline-HT Study Operators.
Pietrantonio F; FADOI-OdC Group; Vinci A, Maurici M, Ciarambino T, Galli B, Signorini A, La Fazia VM, Rosselli F, Fortunato L, Iodice R, Materazzo M, Ciuca A, Cicerchia LCM, Ruggeri M, Manfellotto D, Rosiello F; “DSPMI Group”; Moriconi A. Pietrantonio F, et al. Among authors: iodice r. Sensors (Basel). 2023 Jun 7;23(12):5408. doi: 10.3390/s23125408. Sensors (Basel). 2023. PMID: 37420575 Free PMC article.
111 results